Zantac® Lawsuit
REPRESENTING CLIENTS ACROSS THE U.S.
In September 2019, the FDA announced that it found levels of N-nitrosodimethlylamine (NDMA), a chemical linked with certain cancers, in Zantac® heartburn medication (ranitidine). It was discovered that each Zantac® tablet may contain 3,000 to 26,000 times the FDA approved safe amount of NDMA. The FDA recently expanded this warning to all brand name and generic ranitidine tablets, and asked that they be pulled from shelves immediately. We are seeking to represent clients who have suffered from cancer after taking ranitidine tablets from any of the following brands:
- Zantac®
- Novartis / Sandoz
- Apotex
- Rite Aid
- Wal-Zan® (Walgreens)
- equate™ (Walmart)
Zantac® and other brands failed to warn consumers of the level of NDMA in the product and the potential dangers it could cause. Those who took ranitidine tablets for three months or more and developed stomach, esophageal, intestinal, liver, colon, kidney, bladder, uterine, or pancreatic cancer may be eligible for compensation.
HOW DO RANITIDINE TABLETS CAUSE CANCER?
Ranitidine, the active ingredient in Zantac® and other heartburn medications, reacts when it is exposed to high temperatures, such as those in the human body or in a hot car. The heat causes ranitidine to produce dangerous levels of NDMA, thousands of times higher than the level that the FDA considers safe.
High levels of NDMA have been strongly linked to multiple types of cancers including:
- Stomach
- Esophageal
- Intestinal
- Liver
- Colon
- Kidney
- Bladder
- Uterine
- Pancreatic
The International Agency for Research on Cancer (IARC) and the U.S. National Toxicology Program (NTP) list NDMA as a compound that is carcinogenic to humans. NDMA is also commonly used in research laboratory settings to induce cancer in rats.
OFFICIAL FDA RECALL OF RANITIDINE TABLETS
After investigating levels of toxic NDMA in ranitidine since the summer of 2019, The FDA officially announced that all ranitidine products, including Zantac®, should be removed from shelves immediately because of their public health risk.
CNN reported that the FDA recommends all consumers stop using the drug immediately, dispose of it properly, and not buy more. This announcement highlights how truly dangerous the chemicals in ranitidine tablets can be for its users.
COMPENSATION FOR RANITIDINE CANCER PATIENTS
Consumers are taking legal action against Zantac® and other drug companies for failing to warn consumers of the dangerous NDMA chemicals on their product labels. Many ranitidine tablet users have now developed cancer, which may have resulted from the extended use of the heartburn medication. You may be eligible for a compensation claim IF:
- You’ve been diagnosed with one of the associated cancers (stomach, esophageal, intestinal, liver, colon, kidney, bladder, uterine, or pancreatic)
- You used Zantac® or other ranitidine tablets for three months or more before your diagnosis
Price Armstrong is working to hold drug companies accountable for the damages they have caused. If you or a loved one used ranitidine tablets like Zantac® for three months or more and developed cancer, contact the attorneys at Price Armstrong for a free, confidential consultation. We will work to get you the justice you deserve.
ZANTAC® LAWSUIT FAQS
You likely qualify for the case if (1) you used Zantac® heartburn medication or other ranitidine tablets for three or more months, and (2) you’ve been diagnosed with stomach, esophageal, intestinal, liver, colon, kidney, bladder, uterine, or pancreatic cancer. Contact us today to see if you qualify.
Contact us today so we can confirm that you qualify. Our team will provide a free, confidential consultation over the phone. If you qualify, we will provide you with a standard representation agreement and intake questionnaire. These documents will allow us to begin the process of representing you in the ranitidine litigation and getting you the compensation you deserve.
Studies are still ongoing to determine which cancers may have been caused by ranitidine tablets like Zantac®. Current research suggests that cancers related to the gastrointestinal system are most directly correlated, but research is ongoing and the risks of high levels of ranitidine and NDMA may result in other types of cancer being included in the litigation. Please contact us for more information and a confidential case evaluation.
If you used a different brand name or generic drug containing ranitidine, in addition to or instead of using Zantac®, you may still have been harmed and likely qualify to participate in the litigation. Please contact us to find out more information.
Anyone diagnosed with cancer after taking ranitidine tablets like Zantac® may be eligible for compensation and should seek advice from legal experts. If a family member or loved one qualifies, please call us to discuss the options available to have them included in the litigation.
Our firm operates solely on a contingency fee agreement. That means that we advance all of our costs and our time, and we only receive any fee if we are successful in obtaining compensation for you. There are absolutely no out-of-pocket costs for you to join the case and seek the monetary relief you deserve.
CONTACT US FOR A FREE CASE EVALUATION
If you have been affected by side effects from regular use of ranitidine tablets like Zantac®, contact the attorneys at Price Armstrong. We can help you seek justice and protect your rights throughout the process. We represent clients nationwide with three offices in Birmingham, AL, Tallahassee, FL and Albany, GA. Complete a form, start a chat or call us today at (205) 208-9588 for a free initial consultation and review of your case. Let us fight for you – call now!
